Update on the evaluation, pathogenesis, and management of neurogenic orthostatic hypotension: introduction.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Neurology

• Publication date

  1995-04-01

• Fields of study

  Medicine

• Identifiers
  PMID 11536688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Developing a nomogram to identify patients at risk of orthostatic hypotension in Chinese patients.

  2025cites this paper
• Cerebral hemodynamics in orthostatic intolerance with normal head‐up tilt test

  2016cites this paper
• Orthostatic Hypotension: Mechanisms, Causes, Management

  2015cites this paper
• Menstrual cycle phase does not affect sympathetic neural activity in women with postural orthostatic tachycardia syndrome

  2015cites this paper
• Midodrine for Orthostatic Hypotension: A Systematic Review and Meta-Analysis of Clinical Trials

  2013cites this paper
• Pharmacokinetic and pharmacodynamic effects of midodrine on blood pressure, the autonomic nervous system, and plasma natriuretic peptides: a prospective, randomized, single-blind, two-period, crossover, placebo-controlled study.

  2008cites this paper
• Pathophysiology, Diagnosis, and Treatment of Orthostatic Hypotension and Vasovagal Syncope

  2008cites this paper
• Management of neurogenic orthostatic hypotension: an update.

  2008cites this paper
• Efecto de la suplementación de la dieta con ácidos grasos del tipo n-3 sobre la capacidad funcional de los lesionados medulares.

  2007cites this paper
• Influence of orthostatic hypotension on mortality among patients discharged from an acute geriatric ward

  2006cites this paper
• Impact of the application of the American College of Emergency Physicians recommendations for the admission of patients with syncope on a retrospectively studied population presenting to the emergency department.

  2005cites this paper
• Therapy for immunoglobulin light chain amyloidosis: the new and the old.

  2004cites this paper
• Drug treatment of orthostatic hypotension and vasovagal syncope.

  2003cites this paper
• Prevalence and clinical outcomes of patients with multiple potential causes of syncope.

  2003cites this paper
• New drugs in the future treatment of Parkinson's disease

  2002cites this paper